日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Author Correction: Activation of GPR81 by lactate drives tumour-induced cachexia

作者更正:乳酸激活GPR81驱动肿瘤诱导的恶病质

Liu, Xidan; Li, Shijin; Cui, Qionghua; Guo, Bujing; Ding, Wanqiu; Liu, Jie; Quan, Li; Li, Xiaochuan; Xie, Peng; Jin, Li; Sheng, Ye; Chen, Wenxin; Wang, Kai; Zeng, Fanxin; Qiu, Yifu; Liu, Changlu; Zhang, Yan; Lv, Fengxiang; Hu, Xinli; Xiao, Rui-Ping

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CM313 in Healthy Participants: An Open-Label/Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial

CM313在健康受试者中的药代动力学、药效学和免疫原性:一项开放标签/双盲、随机、安慰剂对照的I期试验

Yu, Shuyan; Wu, Junzhen; Zhao, Junxue; He, Jinjie; Yan, Hongyue; Zhang, Xiang; Yang, Yifan; Song, Han; Hou, Qiaoyun; Guo, Bujing; Qiu, Yanping; Chen, Bo; Xue, Yu; Zhang, Jing

Activation of GPR81 by lactate drives tumour-induced cachexia

乳酸激活 GPR81 导致肿瘤诱发恶病质

Xidan Liu #, Shijin Li #, Qionghua Cui #, Bujing Guo, Wanqiu Ding, Jie Liu, Li Quan, Xiaochuan Li, Peng Xie, Li Jin, Ye Sheng, Wenxin Chen, Kai Wang, Fanxin Zeng, Yifu Qiu, Changlu Liu, Yan Zhang, Fengxiang Lv, Xinli Hu, Rui-Ping Xiao